PARA HealthCare Analytics Weekly eJournal April 14, 2021 by CorroHealth

April 14, 2021

PARA

WeeklyeJOURNAL NEWS FOR HEALTHCARE DECISION MAKERS

Gall Bladder Ejection Fraction Page 2 COVID-19 Fu n er al Expen se Assist an ce Page 22 - BioFir e Respir at or y Pan el Codin g An d Cover age Updat e - Monthly Repetitive Wound Care Service Billing - Ligh t Adju st able Len s Cat ar act Su r ger y

FAST LINKS

- PAMA Reporting Guide - Apr il 1 OPPS Updat es - MCMS Repayment Of COVID-19 Accelerated And Advanced Payments - Updat ed COVID-19 Gu idan ce

M edicar e Un iver sit y

Administration: Pages 1-65 HIM /Coding Staff: Pages 1-65 Providers: Pages 2, 3, 13, 22 Ophthalmology: Page 13 Gastroenterology: Page 2 Wound Care: Page 6 1 24 Outpatient Svcs: Page

Page 21

- Hospice: Page 58 - California Providers: Page 36 - Price Transparency: Pages 15,25 - DM E: Pages 58 - COVID Guidance: Pages 22,35,49

PARA Weekly eJournal: April 14, 2021

ENSURE FOR EJECTION FRACTION

As standard protocol, we use an Ensure-like shake to determine the gallbladder ejection fraction. We only use Kinevac on inpatients or if the patient cannot drink the shake for various reasons. When we originally set up the coding, we were using CPT® 78227 as it "included quantitative measurement of the ejection fraction." Per the CPT® coding book, the question is: To verify if we should be using CPT® 78226 or 78227, if a non-drug product is administered to stimulate the gallbladder to enable determination of the gall blader ejection fraction, cide 78226 must be reported instead of 78227. Is this correct? Answer: There was a 2nd Quarter Coding Clinic in 2019 that addresses this: Question 1 The hepatobiliary (HIDA) duct scan is a nuclear medicine imaging test performed to evaluate whether there are any blockages in the biliary system which includes the liver, gallbladder and the ducts. However, there is a shortage of the medication cholecystokinin (CCK) which is known as a diagnostic aid used to help diagnose medical conditions. We have been performing the HIDA scan using a dietary replacement (Ensure) for the pharmacologic intervention piece of this procedure. Our office has been reporting CPT® code 78227, Hepatobiliary system imaging, including gall bladder when present; with pharmacologic intervention, including quantitative measurement(s) when performed, for the HIDA scan. We are still doing the calculations for the ejection fraction with Ensure instead of CCK. Would it be appropriate to report CPT® code 78227, for the HIDA scan when the Ensure dietary supplement is used in place of cholecystokinin? Answer: Assign CPT® code 78226, Hepatobiliary system imaging, including gallbladder when present, for the HIDA scan performed with the Ensure dietary supplement. It is not appropriate to assign CPT® code 78227 as a fatty meal, such as Ensure, is not considered pharmacological intervention.

PARA Weekly eJournal: April 14, 2021

BIOFIRE® RESPIRATORY PANEL CODING AND COVERAGE UPDATE Effective April 1, 2021, three proprietary CPT® codes for Biofire® respiratory panel lab tests will be deleted ? 0098U, 0099U, and 0100U. The change was listed in the November 2020 CPT® Panel meeting agenda: https://www.ama-assn.org/system/files/ 2021-01/cpt-pla-codes-short.pdf

Some have speculated that since COVID-19 was not among the targets tested in these three CPT®s, Biofire® withdrew the codes from active use. 0202U Deemed Non-Covered. Meanwhile, hospitals and laboratories across the US have found that the 22-target Biofire® respiratory panel HCPCS 0202U is non-covered by most MAC?s through Local Coverage Determinations. This has confounded some purchasers of the test since the national Clinical Lab Fee Schedule rate was hefty $416.78. In its response to comments received in the course of adopting LCD L37764, WPS offers the following rationale to a commenter who attempted to persuade the MAC that multiplex testing for more than five targets should be covered: Local Coverage Article for Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (DL37764) (cms.gov) 3

PARA Weekly eJournal: April 14, 2021

BIOFIRE® RESPIRATORY PANEL CODING AND COVERAGE UPDATE ?The commenter makes a hypothetical argument pointing out that there potentially exists a clinical application for a respiratory viral panel in some patients so as to lead to a better outcome. However, the commenter does not provide evidence that any particular panel (where a panel is a specified group of tests which must be ordered together) or any group of panels has clinical utility for a particular population or for beneficiaries with well identified indications. For coverage purposes Palmetto GBA must make coverage decisions regarding specific panels or specific selections of pathogens for specific indications. As such, while we agree that it is conceivable that there exists a patient population who might benefit from a particular group of multiple respiratory viral tests, at this point no evidence has been brought to our attention regarding how a clinician is to identify such a population for any specific available test. Moreover, the only virus group in the core set of pathogens for which treatment is widely (but still not universally) appropriate is influenza. For those cases in which more than one causative virus could be related to the observed signs or symptoms (either due to overlap of typical symptoms or the presence of atypical symptoms), and diagnosis of a specific causative agent is expected to alter treatment in a way that improves the outcome, the clinician could order individual viral tests for which a result would be expected to lead to clinically actionable information. If new evidence develops demonstrating that a particular panel or the use of a particular set of respiratory viral tests, which match the components of a panel, leads to enhanced patient outcomes we would be willing to reconsider this coverage determination. Draft LCDs and established LCDs limiting coverage of multiplex testing have been adopted by most MACs. Multiplex PCR respiratory viral panels of 6 or more pathogens are deemed not medically necessary and therefore non-covered.

Here are links to a few LCDs from MACs across the country Novita Proposed Local Coverage Determination for Respiratory Pathogen Panel Testing (DL38916) (cms.gov) WPS Local Coverage Determination for MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (L37764) (cms.gov) Noridian Local Coverage Determination for MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (L37315) (cms.gov) CGS Local Coverage Determination for MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (L37348) (cms.gov) Palmetto Local Coverage Article for Billing and Coding: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (cms.gov) First Coast Proposed Local Coverage Determination for Respiratory Pathogen Panel Testing (DL38918) (cms.gov) 4

PARA Weekly eJournal: April 14, 2021

BIOFIRE® RESPIRATORY PANEL CODING AND COVERAGE UPDATE PARA inquired of CMS whether hospitals which had purchased the 0202U test could report a lower target-count CPT®, such as 87631, in lieu of 0202U in order to receive some reimbursement for the spent expense of the 22-target respiratory panel.CMS responded by referring the question to local MACs for guidance. MACs tend to limit interaction to identified provider representatives within each jurisdiction; therefore, PARA recommends that hospitals and laboratories reach out to its regional MAC for this coding guidance. A copy of the email from CMS appears here.

PARA Weekly eJournal: April 14, 2021

MONTHLY REPETITIVE WOUND CARE SERVICE BILLING

ound care departments often take advantage of ?repeater billing?, which consolidates multiple dates of service into one monthly ?repeater? claim (13x Type of Bill) for patients who will return on a weekly basis for ongoing care. This saves registration work for both the hospital and the patient. However, repeater billing by an OPPS provider can result in reduced reimbursement under OPPS, depending on the OPPS status indicator of the services billed. The reduction in reimbursement is avoidable, and back in 2005, CMS stated in MLN Matters CR#3633 ?Providers are strongly encouraged to separate repetitive services from non-repetitive services? ? Some repeater claims for wound care include surgical procedures ranked as status J1 under OPPS, such as 11044, bone debridement. When reporting procedures on a monthly claim with multiple dates of service, payment for lesser procedures billed on the same claim with status J1 procedures are processed as ?packaged? to the J1 payment, resulting in lost reimbursement for different dates of service. The PARA Data Editor CMS tab contains Medicare claims data, including payments, purchased quarterly from CMS for a prior period .Claims may be reviewed by searching one or two HCPCS, and/or by modifier:

PARA Weekly eJournal: April 14, 2021

MONTHLY REPETITIVE WOUND CARE SERVICE BILLING

The claim above is a perfect example.Under OPPS, Medicare packaged payment on a single status J1 procedure, 11044; although additional procedures were performed on different dates of service, no payment was provided because they were billed on the same claim. Had the separate dates of service been separately reported, total reimbursement would have been $10,377.77. (To view the dates of service for each line item, download the CMS report to Excel, and click the ?details? box next to the download button.) A claim with five different dates of service will be paid for a single OPPS status J1 procedure, 11044:

Had separate claims been submitted on the above encounters, reimbursement under OPPS would have been significantly higher:

PARA Weekly eJournal: April 14, 2021

MONTHLY REPETITIVE WOUND CARE SERVICE BILLING

Had separate claims been submitted on the above encounters, reimbursement under OPPS would have been significantly higher:

PARA Weekly eJournal: April 14, 2021

MONTHLY REPETITIVE WOUND CARE SERVICE BILLING

Medicare defines as ?repetitive outpatient services? in Chapter 1 of the Medicare Claims Processing Manual ? General Billing Requirements: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c01.pdf 50.2.2 - Frequency of Billing for Providers Submitting Institutional Claims with Outpatient Services (Rev. 2092, Issued: 11-12-10, Effective: 04-01-11, Implementation: 04-04-11) ?? Services repeated over a span of time and billed with the following revenue codes are defined as repetitive services: Type of Service Revenue Code(s) DME Rental 0290-0299 Respiratory Therapy 0410, 0412, 0419 Physical Therapy 0420 ? 0429 Occupational Therapy 0430 ? 0439 Speech-Language Pathology 0440 ? 0449 Skilled Nursing 0550 ? 0559 Kidney Dialysis Treatments 0820 ? 0859 Cardiac Rehabilitation Services 0482, 0943 Pulmonary Rehabilitation Services 0948 Medicare does not require wound care claims to be reported on a monthly repeater claim basis. It offers hospitals the option of billing non-repetitive outpatient services on a monthly repeater claim, or submitting individual claims, as shown in this illustration from the Medicare Claims Processing Manual, Chapter 1 -General Billing Requirements, 50.2.2 - Frequency of Billing for Providers Submitting Institutional Claims with Outpatient Services:

PARA Weekly eJournal: April 14, 2021

MONTHLY REPETITIVE WOUND CARE SERVICE BILLING

Under OPPS, outpatient claims with more than one APC payment are subject to ?packaging?, and there is no exception applied to procedures performed on separate dates of service.The instructions on page 12 of the 2020 IOCE Specifications (Integrated OCE (IOCE) CMS Specifications V22.1, page 28): https://www.cms.gov/apps/aha/license.asp?file=/files/zip/ioce-quarterly-data-files-v221r0.zip 5.6 Comprehensive APC Processing Effective 1/1/2015 (v16.0), certain high cost procedures which have an SI=J1 are paid an all-inclusive rate to include all services submitted on the claim, except, for services excluded by statute. All allowed, adjunctive services submitted on the claim are packaged into the ?comprehensive? APC payment rate (e.g., the status indicator is changed to N). Multiple comprehensive procedures, if present on the claim in specified combinations, may be assigned to a higher-paying comprehensive APC representing a complexity adjustment. Services that are excluded from the all-inclusive payment retain their standard APC and SI for standard processing. The bottom line--all services rendered during a single outpatient wound care encounter must be reported on the same claim, but services from different wound care encounters risk unnecessarily reduced OPPS reimbursement if they are reported together on a single ?repeater? claim .An encounter begins when a patient arrives at a facility for treatment and terminates when the patient leaves the facility. The Medicare Claims Processing Manual, Chapter 1, Section 50.2.2 sets forth the rules for ?Frequency of Billing for Providers Submitting Institutional Claims with Outpatient Services.? It explains how to separately bill ?non-repeater services? from a claim for repetitive services during the same month: http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c01.pdf 50.2.2 - Frequency of Billing for Providers Submitting Institutional Claims with Outpatient Services (Rev. 2092, Issued: 11-12-10, Effective: 04-01-11, Implementation: 04-04-11) ?Repetitive Part B services furnished to a single individual by providers that bill institutional claims shall be billed monthly (or at the conclusion of treatment). ? ?Where there is an inpatient stay, or outpatient surgery, or outpatient hospital servicessubject to OPPS, during a period of repetitive outpatient services, one bill for repetitiveservices shall nonetheless be submitted for the entire month as long as the provider usesan occurrence span code 74 on the monthly repetitive bill to encompass the inpatient stay,day of outpatient surgery, or outpatient hospital services subject to OPPS. CWF andshared systems must read occurrence span 74 and recognize the beneficiary cannotreceive non-repetitive services while receiving repetitive services, and consequently, is on leave of absence from the repetitive services. This permits submitting a single,monthly bill for repetitive services and simplifies Contractor review of these bills.? Additional information about repetitive and non-repetitive service billing is available in the following MLN article:

PARA Weekly eJournal: April 14, 2021

MONTHLY REPETITIVE WOUND CARE SERVICE BILLING

Additional information about repetitive and non-repetitive service billing is available in the following MLN article: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-NetworkMLN/MLNMattersArticles/downloads/MM3382.pdf

PARA Weekly eJournal: April 14, 2021

MONTHLY REPETITIVE WOUND CARE SERVICE BILLING

Finally, in the original MLN Matters article CR#3633, CMS ?strongly encouraged? providers to report non-repeater services on a separate OPPS claim.The MLN Article has been taken down from the CMS website, but here is the content: MLN Matters CR#3633, effective January 1, 2005 Hospital Billing for Repetitive Services: ? - If an individual OPPS service is provided on the same day as an OPPS repetitive service, the individual OPPS service is to be billed on a separate OPPS claim containing the individual service and all packaged and/or related services. Note: Providers are strongly encouraged to separate repetitive services from non-repetitive services effective January 1, 2005. However, to allow sufficient time for providers to adjust their operations, CMS has delayed editing that would enforce providers to separate repetitive services from non repetitive services. Providers will be given advance notice of the effective date for such editing per a future MLN Matters article. ? Note: Chemotherapy administration is no longer a repetitive service as defined in the Medicare Claims Processing Manual (Pub. 100-04, Chapter 1, Section 50.2.2). However, chemotherapy is commonly administered during multiple encounters in a month. Where there are multiple encounters for chemotherapy or other non-repetitive services in a month, they may all be reported on the same claim, or they may be billed separately.

PARA Weekly eJournal: April 14, 2021

LIGHT ADJUSTABLE LENS CATARACT SURGERY

The Light Adjustable Lens is a new kind of intra-ocular lens (IOL) that contains materials which can be adjusted to correct the patient?s vision after implantation by means of UV light delivered through a Light Delivery Device. It is FDA approved for cataract patients with preexisting astigmatism. Beginning two to three weeks after surgery, the patient undergoes several treatments using a device that delivers the UV light.The light treatments take about 90 seconds, and are repeated 3 or more times, separated in time by a few days to a week between visits. Here?s a link and an excerpt from an LAL equipment vendor that explains the LAL: https://www.rxsight.com/us/ healthcare-professionals/ For Medicare beneficiaries, the vision-correcting properties of any IOL isnon-covered.Medicare will cover the cost of an ordinary IOL for medically necessary cataract surgery, but the extra features for vision correction fall to patient liability.. We recommend providing an Advance Beneficiary Notice to patients with full disclosure of the patient?s liability for costs related to both the lens and the post-surgical visits to adjust the lens. There is no HCPCS specifically for the LAL lens, we would expect it to be reported with two HCPCS ? one line reporting the HCPCS for an ordinary lens (V2630), and a second line reporting the non-covered cost of the astigmatism-correcting function, V2787: (see next page).

PARA Weekly eJournal: April 14, 2021

LIGHT ADJUSTABLE LENS CATARACT SURGERY

There are two services related to LAL surgery?the surgery to implant the lens, and the follow-up visits required to adjust the lens to achieve optimal vision correction. While the surgery is typically performed on an outpatient basis at a hospital or an ambulatory surgery center, the post-operative light treatments can be performed in the office setting. Surgery and Lens: To appropriately price the LAL surgery, hospitals should consider the added cost of the lens, and whether the follow-up visits required to adjust the lens post-surgically will be performed in the hospital setting.None of the post-surgical visits for lens adjustment would be considered covered by Medicare, because the purpose of the visit is to correct the vision for astigmatism ? a non-covered service. PARA holds that vision-correcting IOL?s should be priced reasonably, to avoid earning an excessive profit at the patient?s expense. To that end, we recommend that the hospital charge for the non-covered portion of an LAL lens (only the lens) would be at hospital cost less $267.59, which is the average amount that Medicare allocates for an ordinary lens when setting OPPS rates of reimbursement.The OPPS APC payment for the traditional cataract procedure, 66984, attributes $267.59 to the cost of the lens in cataract procedures (per 2021 Addendum P). Consequently, the cost of the LAL lens that exceeds $267.59 should be that portion charged to the patient for the non-covered features of an LAL.

Post-surgical adjustments ?The additional work and the LAL equipment required to adjust the lens to optimize the patient?s vision post-surgically may be performed in most outpatient settings, hospital, ASC,or office. The adjustment sessions do not require a hospital environment. The post-op adjustment visits contain two sources of add-on cost--the equipment required to deliver the light treatments, and the professional fee for the physician?s work of adjusting the lens. PARA recommends that the hospital inform the prospective patients in writing (an ABN would be ideal) of the non-covered portion of the cost of the LAL lens, and collect the patient portion of the cost in advance of the surgery. 14

PARA Weekly eJournal: April 14, 2021

A GUIDE COMPLIANCE

FOR

LABORATORIES & HOSPITALS Protecting Access To Medicare Act Laboratory Private Payer Rate Reporting Requirements

Pr icin g | Codin g | Reim bu r sem en t | Com plian ce 15

PARA Weekly eJournal: April 14, 2021

BACKGROUND

PAMA stands for Pr ot ect in g Access t o M edicar e Act of 2014 and was published by The White House Office of Management and Budget to modify the Medicare reimbursement rate methodology for lab services.

In t r odu ct ion CMS created the CLFS to guarantee the new fee schedule continues to ensure adequate access to lab services for Medicare beneficiaries. But, the pre-PAMA Medicare Clinical Lab Fee Schedule (CLFS) payments were based on 1984 cost data and sometimes updated for inflation. A limited reconsideration process was in place for new tests.The hope for the new CLFS was that by performing a market-based pricing exercise, pricing could be brought up to date and in-line with current practices.

PARA Weekly eJournal: April 14, 2021

THE DETAILS

PAMA reporting requirements apply to any ?applicable laboratory.? An applicable laboratory is a laboratory that receives a majority of its Medicare revenue under the CLFS, the Physician Fee Schedule (?PFS?), or the new section 1834A of the Social Security Act, as added by PAMA.

Wh at 's An Applicable Lab? - A laboratory, as defined in CLIA, that bills Medicare Part B under its own NPI

Hospital Labs Serving: - Inpatients - Outpatients - Non-Patients (?Outreach?)

Physician Office Labs Performing: - Point of Care/Traditional Tests - Provider-Performed Microscopy - Pathologists?Practices

Independent Labs Performing: - Standard Tests - Drug Abuse Testing - Molecular Diagnostics 17

- And receives the majority of its Medicare revenue from the PFS or CLFS - And receives more than $12,500 Medicare revenue from the CLFS in a year - The $12,500 threshold does not apply to a single laboratory that furnishes an ADLT (but does apply to any CDLTs that the laboratory performs)

PARA Weekly eJournal: April 14, 2021

THE COST OF NON-COM PLIANCE

CM Ps

WHAT LEADERS NEED TO KNOW

?We are revising the certification and CMP (Civil Monetary Penalties) policies in the final rule to require that the accuracy of the data be certified by the President, CEO, or CFO of the reporting entity, or an individual who has been designated to sign for, and who reports directly to such an officer. Similarly, the reporting entity will be subject to CMPs for the failure to report or the misrepresentation or omission in reporting applicable information.?

Current CM P Rate: $10,017 Per Day. 18

PARA Weekly eJournal: April 14, 2021

REQUIREM ENTS CAN BE CONFUSING

LETPARAPOINTTHE WAYTHROUGHTHE LABPAYMENT REPORTINGMAZE 19

PARA Weekly eJournal: April 14, 2021

HELP IS HERE

PARA has developed a 30-minute online presentation that can help keep you compliant with PAMA laboratory rate and reporting requirements. It's vital information for all clinical laboratories. Click t h e sign s t o w at ch . Th en con t act you r PARA Accou n t Execu t ive f or m or e in f or m at ion .

Our amazingguides. Ran di Br an t n er

San dr a LaPlace

Violet Ar ch u let -Ch iu

Vice President of Analytics

Account Executive

Senior Account Executive

rbrantner@hfri.net

splace@para-hcfs.com

varchuleta@para-hcfs.com

719.308.0883

800.999.3332 x 225

800.999.3332 x219

PARA Weekly eJournal: April 14, 2021

NSG OFFERS FREE MEDICARE PART A BILLER TRAINING

PARA reminds our readers that National Government Services (NGS) offers Medicare Part A web-based training sessions to all Part A providers free of cost.A list of the upcoming sessions is available through the following link: http://view.email.ngsmedicare.com/?qs=3eb841224ce3455aef5739714fdecca8 36161f6406ffaa1d7d507e327278090c149804501a1c476a6f951dee71284d554 b292171f77f16e71a73906837be352e790b14558b 766b00b045b2e44a07e8105c166d67e82ae5a5

NGS also offers computer-based training through its Medicare University portal.To access these sessions, you must register and create a log in. Once logged in, registrars have access to thousands of courses.

PARA Weekly eJournal: April 14, 2021

COVID-19 FUNERAL ASSISTANCE PROGRAM

As part of the Coronavirus Response and Relief Supplemental Appropriations Act (CRRSA) of 2021 and the American Rescue Plan Act of 2021, FEMA may aid with funeral expenses that occurred after January 20, 2020.Applications opened on April 12, 2021, to ?ease of some of the financial stress and burden caused by the virus.? Applicants will need to provide a death certificate that indicates the patient died because of coronavirus while in the United States or U.S. territories.The patient did not have to be a United States citizen, non-citizen, or qualified alien.

The COVID-19 Funeral Assistance Line Number: 844-684-6333|TTY:800-462-7585 A U.S. citizen, non-citizen, or qualified alien who incurred funeral and related expenses will need to provide receipts or contracts showing the responsible party. Expenses may include but are not limited to: - Transfer of remains - Marker or headstone - Clergy or officiant services -

Cremation or burial costs Funeral ceremony arrangements Funeral home equipment or staff Costs associated with producing and certifying death certificates Transportation of up to persons to identify the deceased individual Casket or urn

Additionally, applicants will be asked for the following information, so FEMA suggest preparing these before calling: - Deceased individual?s SSN, date of birth, where the individual passed away - Information on donations, grants, or other funeral assistance received - Routing and account number for the applicant for direct deposit of funds Qualified individuals may apply for assistance for more than one person who died from coronavirus. Financial assistance is limited to a max of $9,000 per funeral and a maximum of $35,500 per application per state, and life insurance proceeds are not considered a duplication of Funeral Assistance benefits. Pre-planned and pre-paid burials or funerals are not eligible for reimbursement.

PARA Weekly eJournal: April 14, 2021

COVID-19 FUNERAL ASSISTANCE PROGRAM

FEMA will not accept online applications but has set up a toll-free phone number for questions and complete an application with an agent.A caller may experience busy signals as FEMA works through technical issues, but, currently, there is no deadline to apply. FEMA offers a FAQ page at the following site: https://www.fema.gov/disasters/coronavirus/economic/funeral-assistance/faq

References: Congress.gov ? American Rescue Plan Act of 2021 https://www.congress.gov/bill/117th-congress/house-bill/1319

Consolidated Appropriations Act, 2021 https://www.congress.gov/bill/116th-congress/house-bill/133/text

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

CMS issued Transmittal R1066CP with an MLN article ?April 2021 Update of the Hospital Outpatient Prospective Payment System (OPPS)? on March 8, 2021.Eighteen HCPCS were deleted effective 4/1/2021, some of the deleted codes have been replaced with new HCPCS codes.Most of the newly added HCPCS were for proprietary laboratory testing and new pharmaceuticals. https://www.cms.gov/files/document/mm12175.pdf

PARA will advise chargemaster clients by email of any line items in the hospital CDM require update as a result of a deleted HCPCS code; we will also provide a replacement HCPCS where available.(To take full advantage of PARA chargemaster support, clients are encouraged to upload a current CDM at least quarterly.) The following summarizes the OPPS updates effective April 1, 2021. - Revised APC assignment: Effective April 1, 2021, CMS reassigned OPPS APCs to Pfizer and Moderna COVID-19 administration codes. (The HCPCS are unchanged, only the payment APC changed.)

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

Administration codes assigned rates from Addendum B will be available at the following webpage: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS/ Addendum-A-and-Addendum-B-Updates *Note:At time of print, the Addendum A and B updates were not yet published on the CMS.gov website

The COVID vaccine codes with updated APC assignments are below:

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

- Johnson & Johnson COVID-19 Vaccine: Effective February 27, 2021, under the FDA Emergency Use Authorization (EUA) of the Johnson & Johnson (Janssen) COVID-19 vaccine, providers may report HCPCS91303 for the vaccine product and 0031A for its single-dose administration. The payment rates will be published in the April Addendum B - Monoclonal AB Therapy for COVID-19: CMS establish new HCPCS codes for Monoclonal Antibody Therapy treatments for COVID-19 effective on the date the FDA provided an EUA for each. Medicare covers these treatments during the Public Health Emergency (PHE) in accordance with Section 3713 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). Medicare covers and pays for the monoclonal therapy through the COVID-19 vaccine program. Medicare expects that, at least initially, providers will receive the drug products free of charge.When the provider receives the product at no cost, Medicare will reimburse the administration of the monoclonal antibody drugs when reported with the unique M-code, it is not necessary to report the drug itself on claims to Medicare. The following chart lists the effective dates and payment rates for each monoclonal antibody therapy code.

- New PLA Codes:Effective April 1, 2021, the AMA established the six following Proprietory Lab Analyses (PLA) codes; these have been assigned OPPS status A (paid under fee schedule) or Q4 (conditionally packaged laboratory services): (See following page.)

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

- New HCPCS Code C9776: Effective April 1, 2021, report add-on code HCPCSC9776for intra-operative near-infrared fluorescence imaging of major extra hepatic bile duct(s) with intravenous administration of indocyanine green. This laser technique, which uses indocyanine (ICG) green, provides enhanced real-time visualization of cystic, common bile, or common hepatic ducts during open or laparoscopic cholecystectomy procedures.

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

- New HCPCS Code C9777: Effective April 1, 2021, report C9777 for Esophageal Mucosal Integrity Testing by Electrical Impedance.This procedure is used to detect esophageal mucosal changes that result from chronic Gastroesophageal Reflux Disease (GERD) or Eosinophilc Esophagitis (EoE.)

- Change of Long Descriptor for HCPCS C9761: Effective October 1, 2020, the long descriptor for HCPCS code C9761 as shown below

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

- Status Indicator Corrections: In the January 1, 2021 Addendum B, CMS incorrectly listed G2061, G2062 and G2063 with a status indicator of A (paid by MACs under a fee schedule or payment system other than OPPS.) These codes were deleted effective December 31, 2020 and were replaced with CPT® codes 98970, 98971 and 97972 which CMS incorrectly assigned to status indicator B (Not paid under OPPS.) To correct these errors, CMS made the following changes with a retroactive effective date of January 1, 2021.

- Additional Status Indicator Changes: In the January 2021 OPPS, CMS incorrectly assigned G2010 and G2012 with status indicator of A (Paid by MACs under a fee schedule or payment system other than OPPS.)G2211 was incorrectly assigned status indicator of N (payment is packaged into payment for other services.) To correct these errors, each of these codes are assigned status indicator B (Not paid under OPPS) with an effective date of January 1, 2021.

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

Status Indicator Corrections: In the January 1, 2021 Addendum B, CMS incorrectly listed G2061, G2062 and G2063 with a status indicator of A (paid by MACs under a fee schedule or payment system other than OPPS.) These codes were deleted effective December 31, 2020 and were replaced with CPT® codes 98970, 98971 and 97972 which CMS incorrectly assigned to status indicator B (Not paid under OPPS.) To correct these errors, CMS made the following changes with a retroactive effective date of January 1, 2021.

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

- Change of HCPCS for DecisionDx-Melanoma test: When DecisionDx-Melanoma test was approved as an ADLT on May 17, 2019, there was no CPT® code assigned to the test .In the October 2019 Update to OPPS labs were instructed to report this test with an unlisted code,81599(unlisted multianalyte assay with algorithmic analysis) with identifier ZB1D4. Effective January 1, 2021,DecisionDx-Melanomatest was assigned CPT® code81529(Oncology (cutaneous melanoma), mrna, gene expression profiling by real-time rt-PCR of 31 genes (28 content and 3 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence risk, including likelihood of sentinel lymph node metastasis).CPT® code 81529 was assignedstatus indicator A (Paid by MACs under a fee schedule or payment system other than OPPS.) Also, effective January 1, 2021, the status indicator for the unlisted code81599was returned to E1 (Not paid by Medicare when submitted on outpatient claims - any outpatient bill type.) - TIVUS? : A treatment for pulmonary arterial hypertension (PAH),Therapeutic Intravascular Ultrasound (TIVUS) employs a catheter in an intravascular technology that interrupts nerve conduction surrounding blood vessels and other structures.The ultrasound waves heat the nerves to necrosis which interrupts nerve conduction.This ablation results in decreasing sympathetic hormones from the nerves, which, in turn, relaxes and reduces resistance and pressure in the vessels. Effective April 1, 2021, the OPPS status of the TIVUS procedure HCPCS code0632T(percutaneous transcatheter ultrasound ablation of nerves innervating thepulmonary arteries, including right heart catheterization, pulmonary artery angiography, and all imagingguidance) from E1 (excluded from coverage) to toJ1(hospital Part B services paid through a comprehensive APC.)Additional information on TIVUS is available through the following webpage: https://sonivie.com/tivus - Drugs, Biologicals and Radiopharmaceuticals - New Pass-through Status: The following HCPCS codes will be assigned Pass-Through Status indicator G effective April 1, 2021:

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

- Expiring Pass-through Status: Effective April 1, 2021, pass-through status on the following HCPCS codes will change from a status indicator G to K (Paid under OPPS by APC.)

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

Newly Established HCPCS Codes for Drugs, Biologicals and Radiopharmaceuticals: The following seven new codes will replace current HCPCS codes beginning April 1, 2021

- Two HCPCS are deleted effective April 1, 2021:

- Retroactive Status Indicator Changes: The following drug status indicator change is retroactive from January 1, 2021, through March 31, 2021:

PARA Weekly eJournal: April 14, 2021

APRIL 1, 2021 OPPS UPDATES

- Updates on Drugs and Biologicals with payments based on Average Sales Price (ASP): - Most nonpass-through, Non 340B Program = ASP +6 percent of reference product for biosimilars) - Nonpass-through, acquired through 340B Program = ASP ? 22.5 percent of 340B acquired biosimilar - Single payment of ASP + 6 percent for pass-through to provide payment for the acquisition cost and pharmacy overhead - Based on OPPS/ASC final rule comments, values for many drugs and biologicals changed based on sales price from third quarter CY 2020.The full updated list will be available at the April 2021 update of OPPS Addendum A and B : https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS - Restated ASP Methodology Payment Rates: quarterly retroactive correction to some drugs and biological payment rates will be available on the first date of the quarter at the following CMS website: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS/ OPPS-Restated-Payment-Rates - Coverage Determination: CMS reminds us that HCPCS codes and payment rates demonstrate how services, products, or procedures may pay if covered by Medicare.To determine coverage, consult the local MAC for HCPCS code coverage limitations. CMS References: - Change Request (CR) 12175/ Medicare Claim Processing Transmittal 10666:https://www.cms.gov/files/document/r10666cp.pdf

Addendum A and Addendum B Updates:* https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ HospitalOutpatientPPS/Addendum-A-and-Addendum-B-Updates *Not available at time of this print (3/15/2021)

PARA Weekly eJournal: April 14, 2021

CMS REPAYMENT OF COVID-19 ACCELERATED AND ADVANCED PAYMENTS

On April 01, 2021, CMS released a Special Edition Transmittal to alert all Medicare providers and suppliers who requested and were issued Accelerated an Advance Payments (CAAPs) from CMS due to the COVID-19 Public Health Emergency (PHE). The purpose of the CMS Transmittal is to alert all Medicare providers and suppliers who received CAAPs, that CMS began the recovery of those payments on March 30, 2021. The actual recovery date depends on the first anniversary of the receipt of the first payment. Further, CMS will show the recoupment on the remittance advices issued for Medicare Part A and B claims that are processed after the 1styear anniversary of issuing the first payment. The recoupment will appear as an adjustment in the Provider-Level Balance (PLB) section of the remittance advice. Institutional providers entitled to receive Periodic Interim Payments (PIP) should note, recoupment will be from issued (PIPs) rather than in reconciliation and settlement of final cost reports. https://www.cms.gov/files/document/se21004.pdf

PARA Weekly eJournal: April 14, 2021

MEDI-CAL COVID VACCINE CLAIM SUBMISSION

The Department of Health Care Service (DHCS) submitted a federal waiver request in December to the Centers for Medicare and Medicaid Services (CMS) seeking federal approval to cover the cost of vaccine administration for beneficiaries that have restricted scope coverage. The waiver includes vaccine coverage for beneficiaries who are enrolled in the Family Planning, Access, Care and Treatment (Family PACT) program as well as the Uninsured Group Program for COVID-19. DHCS has also submitted a State Plan Amendment to request approval from CMS to reimburse Federally Qualified Health Centers (FQHCs) and Rural Health Clinics (RHCs) a fee-for-service rate for vaccine administration when the encounter does not meet all of the requirements of a billable visit (i.e. vaccine-only administration). Providers who have administered the COVID-19 vaccines to Medi-Cal beneficiaries who are included in: - The Family PACT program - The COVID-19 Uninsured Group program are advised to hold submission of claims pending further guidance from DHCS. Similarly, FQHCs and RHCs should hold claims for vaccine-only administration to the extent the encounter does not meet the requirements of a billable visit or the beneficiary being served is in one of the identified populations above. Policy and reimbursement guidance will be updated upon additional CMS guidance and/or approvals of the requested waiver/State Plan Amendment. Updates regarding IHS-MOA 638 clinics are forthcoming. Providers with questions should contact the Telephone Service Center (TSC) at1-800-541-5555. The TSC is available 8 a.m. to 5 p.m., Monday through Friday, except holidays. Border providers and Out-of-State billers billing for in-state providers should call( 916) 636-1200. https://files.medi-cal.ca.gov/pubsdoco/newsroom/newsroom_30717_71.aspx?_cldee= bW1jbWlsbGFuQHBhcmEtaGNmcy5jb20%3d&recipientid=contact-9212cfb6eaf5ea11a815000d3a5bf119 -ad7e1d690b2442a98883aeee6869497e&esid=6fabf100-4888-eb11-a812-00224809d41c

PARA Weekly eJournal: April 14, 2021

CAPTURING UPSTREAM MEDICAL NECESSITY DOCUMENTATION

M edi care?s Nati onal Coverage Determi nati ons (NCDs) and Local Coverage Determi nati ons (LCDs) began as a fai rly strai ghtforward matchi ng game. A particular service must report one of the covered diagnoses to support medical necessity. The most common medical necessity requirements apply to lab tests--most major EHR systems offer a built-in medical necessity evaluator to determine if the referring physician provided a covered ICD10 diagnosis code and assist in generating an ABN if the diagnosis is insufficient. However, over the years, medical necessity requirements have become more complex, particularly for high-dollar procedures such as Implantable Cardiac Defibrillators and PET scans. Many hospitals have no effective process to check more complex medical necessity requirements. PARA recommends adopting processes that add documentation to support medical necessity to the hospital medical record prior to billing Medicare for services subject to an NCD or LCD. This may be accomplished through documenting an attestation from the performing or ordering provider as a precondition of providing expensive surgical services.We provide a few examples on the last two pages of this paper. Medicare coverage information (NCDs and LCDs) is available on the PARA Data Editor Calculator feature ? enter a HCPCS or a keyword into the ?Codes and/or Descriptions? field, and select the report ?Medicare Coverage? on the right, as illustrated:

PARA Weekly eJournal: April 14, 2021

CAPTURING UPSTREAM MEDICAL NECESSITY DOCUMENTATION

The resulting report will offer a hyperlink to the NCD or LCD or Local Coverage Article with details on the requirements to establish medical necessity (screenshot on the following page.)

Since October 2020, Medicare?s Recovery Audit Contractors (RAC?s) have been auditing whether hospital medical records support the medical necessity requirements for automatic implantable cardio defibrillators (AICD?s.) Here?s a link to Medicare?s Approved Recovery Audit Contractor Issues List: 0195-Implantable Automatic Defibrillator- Inpatient Procedure: Medical Necessity and Documentation Requirements | CMS

PARA Weekly eJournal: April 14, 2021

CAPTURING UPSTREAM MEDICAL NECESSITY DOCUMENTATION

The requirements of NCD 20.4, which apply to most AICD patients, include evidence of the physician?s ?formal shared decision making visit?with the patient before undergoing an AICD procedure. In most cases, the hospital medical record will not contain information on a physician visit performed outside the hospital. The RACs have seized upon this weakness in documentation ? and have identified an easy and rewarding target for high-dollar RAC recoveries. Within a few minutes of receiving the hospital medical records for an AICD case, RAC auditors can determine whether the hospital?s AICD procedure documentation includes evidence of the?formal shared decision making visit.? Claims without the documentation are identified as non-covered, and the RAC promptly sends a recoupment request.The recoupment of an inpatient AICD case is generally between $30,000 and $80,000 ? a big payday for light work at the expense of hapless hospitals which didn?t comprehend the need to obtain evidence of the shared decision making visit for the hospital record. While it may seem unfair to hold hospitals responsible for physician activities, the Medicare Program Integrity Manual explains that when an entity responds to an additional documentation request, the entity audited is responsible for submitting documentation that meets medical necessity requirements, even if that documentation exists in the records of another entity: https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/pim83c03.pdf

Hospitals should carefully evaluate whether complex medical necessity requirements have been met before performing expensive procedures, rather than finding out at a later date that payments will be recouped due to a RAC audit. PARA advises hospitals to prepare brief physician attestations such as those found on the following pages and incorporate this documentation into the hospital medical record prior to performing services subjected to complex medical necessity standards. Please note that the attestations must offer both medically necessary rationale and the opportunity to report a non-qualifying rationale ? hospitals should not ?drive? physicians to select only the options that support medical necessity.

PARA Weekly eJournal: April 14, 2021

CAPTURING UPSTREAM MEDICAL NECESSITY DOCUMENTATION

However, suppose a physician?s response indicates that a Medicare beneficiary service does not meet Medicare medical necessity standards. In that case, the hospital should decline to schedule or perform the procedure unless and until the patient has signed an Advance Beneficiary Notice indicating that the patient accepts full financial liability. Additional information about Medicare?s Advance Beneficiary Notice can be found at: https://www.cms.gov/Medicare/Medicare-General-Information/BNI/ABN

Physicians:Your attestation will add required documentation to the hospital medical record to ensure that Medicare?s medical necessity requirements have been met.For more information, review the requirements at https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/ Downloads/MM10865.pdf 40

PARA Weekly eJournal: April 14, 2021

CAPTURING UPSTREAM MEDICAL NECESSITY DOCUMENTATION

PARA Weekly eJournal: April 14, 2021

CLAIM TIPS FOR BILLING MISCELLANEOUS ITEMS

Or Test in g Codes En din g In 99, J3490 an d J3590

All medical billers and AR follow-up teams have experienced billing or claim denials because there is a ?miscellaneous? HCPCS on a claim. The reason is because miscellaneous codes do not provide adequate information for the item being billed. Unlike established HCPCS for standard procedures and testing, most payers will manually calculate the reimbursement for the claim line reporting the miscellaneous item or testing. To do this process, however, the provider is expected to supply the additional information on the claim upon submission. The type of information required however, varies on the type of miscellaneous service or item that is being reported on the claim. For example: - If the service is a surgery, an operative report will be required to be submitted with the claim submission. This allows the payer to review the procedure and adjudicate the claim correctly - If the service is a diagnostic test, clinical notes should be included. The clinical notes should clearly and precisely describe the patient?s diagnosis, the full name of the test performed and the results of the test - If the item is a DME item, the name of the item, a full description of the item, the name of the manufacturer, the product code/number and a copy of the invoice should be included with the claim submission - If the miscellaneous item is a drug, the claim should contain the full name of the drug, the manufacturer, strength and dosage, NDC code for the drug and route of administration. This would apply to anesthesia agents - **Special note for 80299: The name of the drug being tested must be indicated in Box 19 of the CMS 1500 claim form (remarks field) or in Box 80 of the UB04 claim In the tables on the follow pages of this article, are examples of various procedures and items for which this article is applicable.

PARA Weekly eJournal: April 14, 2021

CLAIM TIPS FOR BILLING MISCELLANEOUS ITEMS

PARA Weekly eJournal: April 14, 2021

CLAIM TIPS FOR BILLING MISCELLANEOUS ITEMS

PARA Weekly eJournal: April 14, 2021

CLAIM TIPS FOR BILLING MISCELLANEOUS ITEMS

PARA Weekly eJournal: April 14, 2021

CLAIM TIPS FOR BILLING MISCELLANEOUS ITEMS

PARA Weekly eJournal: April 14, 2021

CLAIM TIPS FOR BILLING MISCELLANEOUS ITEMS

PARA Weekly eJournal: April 14, 2021

CLAIM TIPS FOR BILLING MISCELLANEOUS ITEMS

PARA Weekly eJournal: April 14, 2021

COVID-19 UPDATE

As Of M ar ch 16, 2021 PARA Healt h Car e An alyt ics continues to update COVID-19 coding and billing information based on frequently changing guidelines and regulations from CMS and payers. All coding must be supported by medical documentation. Wh at you w ill f in d in t h is im por t an t u pdat e: - New link to the CDC ICD-10 tool - Updated information on Remdesivir, the FDA-approved COVID-19 treatment for most adults - New MAC payment link and table for pricing of COVID-19 lab tests - Updated language for RHCs and FQHCs regarding billing of MABs and vaccines - Easier to read sections for Condition Codes and Modifiers - New information on the CR/DR https://apps.para-hcfs.com/para/Documents/COVID-19%20(Updated%2003-16-2021).pdf

Download the updated Comprehensive COVID-19 Billing and Coding Guidebook by clicking the link above or the document to the right.

Updat ed M ar ch 16, 2021

PARA Weekly eJournal: April 14, 2021

THE COM PLIANCE GUIDE

pr t r a i ce ns pa

2021 50

PARA Weekly eJournal: April 14, 2021

There is still time to achieve readiness for the critical Price Transparency Rule. PARA can help.

PARA Weekly eJournal: April 14, 2021

THE CLOCK IS TICKING DATES, RULES & REGS The CMS final rule (CMS-1717-F2) aims to make hospital price information readily available to patients, so they can compare costs and make more informed healthcare decisions. Meeting the deadline and maintaining compliance will be no small endeavor for providers. Complying with the mandate will be a large undertaking that requires multi-disciplinary coordination. PARA HealthCare Analytics and HFRI can help navigate the dates, the rules and the regulations.

REQUIREMENT #1 By Jan u ar y 1, 2021, h ospit als ar e r equ ir ed t o be in com plian ce w it h t h e Hospit al Pr ice Tr an spar en cy r equ ir em en t s set f or t h in t h e CY 2020 Hospit al Ou t pat ien t PPS Policy Ch an ges (CM S-1717-FS).

REQUIREMENT #2 A com pr eh en sive m ach in e-r eadable f ile t h at in clu des t h e specif ic st an dar d ch ar ges f or all h ospit al it em s an d ser vices.

REQUIREMENT #3 A con su m er -f r ien dly display t h at in clu des t h e st an dar d ch ar ges f or at least 300 "sh oppable" ser vices t h at ar e gr ou ped w it h ch ar ges f or an cillar y ser vices t h at ar cu st om ar ily pr ovided by t h e 52 h ospit al.

PARA Weekly eJournal: April 14, 2021

SOLUTIONS FOR HOSPITALS THE PARA PTT In speaking with hospital associations, clients, and business vendor groups, we are finding that we are one of the only vendors who can completely satisfy, to the letter of the law, both CMS requirements in a fully customizable manner. Providers will need to publish both machine-readable format files and the patient facing price estimator is a value-add service for enhancing price transparency. PARA will use the CMS Extract file embedded in the Price Transparency Tool tab via the PARA Dat a Edit or to build the shoppable items/bundles. This can be done by the hospital, coupled with PARA?s guidance to ensure all primary procedures are linked to its customarily paired ancillary services. Turnaround time for the Pr ice Tr an spar en cy Tool is 60 days from submission of completed data. There is no limit at this time on how many clients PARA can assist with the CMS?2021 price transparency requirements as we are constantly monitoring workload and innovating our automation to support the data mining need for this initiative.

PARA Weekly eJournal: April 14, 2021

FROM <THIS, TO THIS> TAKING CONSUMERS FROM THE STONE AGE TO THE DIGITAL AGE

M EET THE T EAM

Violet Ar ch u let -Ch iu

San dr a LaPlace

Ran di Br an t n er

Senior Account Executive

Account Executive

Vice President of Analytics

varchuleta@para-hcfs.com

splace@para-hcfs.com

rbrantner@hfri.net

800.999.3332 x219

800.999.3332 x 225

719.308.0883

PARA Weekly eJournal: April 14, 2021

CAPABILITIES AND SERVICES To ensure consumers will be able to browse for healthcare services in the same way they shop for other goods and services online, hospitals partner with PARA Healt h Car e An alyt ics, an HFRI company that has been providing hospitals and health systems with pricing, reimbursement, coding, and contract management services since 1985. PARA works closely with clients to deploy robust and accurate pricing capabilities for area healthcare consumers. The PARA solution includes a patient-facing estimator engineered to deliver user-friendly, procedure-level estimates reflecting patients?specific coverage limits. Providing consumers with the ability to effectively shop for healthcare services is essential as more employers transition to high-deductible health plans. Peter Ripper, CEO of PARA Healt h Car e An alyt ics, has led his team to design a solution that will provide meaningful, easy-to-understand information for healthcare consumers. With the healthcare providers facing a range of new financial pressures due to the COVID-19 pandemic, PARA has pushed to ensure that the critical but complex transparency rule can be implemented in a timely, cost-effective and consumer-friendly manner. We look forward to helping other systems who may be struggling to achieve price transparency.

PARA Weekly eJournal: April 14, 2021

WATCH YOUR HOSPITAL'S BRIGHT FUTURE UNFOLD With The Help Of Our Price Transparency Tool

PRESS HERE

PARA Weekly eJournal: April 14, 2021

PRICE TRANSPARENCY: CLARIFYING THE UNKNOWN

Let us clarify t he fact s, t he quest ions and uncert aint ies about Price Transparency. Click on the video clip below and watch how PARA Healt hCare Analyt ics and HFRI can ease the anxieties of hospital compliance executives.

PARA Weekly eJournal: April 14, 2021

MLN CONNECTS

PARA invites you to check out the mlnconnects page available from the Centers For Medicare and Medicaid (CMS). It's chock full of news and information, training opportunities, events and more! Each week PARA will bring you the latest news and links to available resources. Click each link for the PDF!

Th u r sday, Apr il 8, 2021

New s -

PEPPERs for LTCHs, CAHs, IRFs, IPFs, Hospices, & SNFs Preparedness Resources: Cybersecurity & Post-Acute Sequelae of SARS-CoV-2 Minority Health: Medicare Covers Preventive Services

Com plian ce -

Hospice Aide Services: Enhancing RN Supervision

Claim s, Pr icer s, & Codes -

OPPS Pricer File: April 2021

Even t s -

Changes in the Hospice Item Set Manual V3.00 Webinar ? April 15 Medicare Part A Cost Report: Easier File Uploads for e-Filing in MCReF Webcast ? April 29

M LN M at t er s® Ar t icles -

Quarterly Update for the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program (CBP) - July 2021 Quarterly Update to the National Correct Coding Initiative (NCCI) Procedure-to-Procedure (PTP) Edits, Version 27.2, Effective July 1, 2021 Update to the Payment for Grandfathered Tribal Federally Qualified Health Centers (FQHCs) for Calendar Year (CY) 2021 April 2021 Update of the Ambulatory Surgical Center (ASC) Payment System Penalty for Delayed Request for Anticipated Payment (RAP) Submission ? Implementation ? Revised

Pu blicat ion s -

How to Use the Medicaid NCCI Tools Hospital Value-Based Purchasing ? Revised

M u lt im edia -

Dementia Care Call: Audio Recording & Transcript View this edition as PDF (PDF)

PARA Weekly eJournal: April 14, 2021

There was 1 new or revised MedLearns released this week. To go to the full Transmittal document simply click on the screen shot or the link.

FIND ALL THESE MEDLEARNS IN THE ADVISOR TAB OF THE PDE

PARA Weekly eJournal: April 14, 2021

The link to this MedLearn MM12068

PARA Weekly eJournal: April 14, 2021

There were 3 new or revised Transmittals released this week. To go to the full Transmittal document simply click on the screen shot or the link.

FIND ALL THESE TRANSMITTALS IN THE ADVISOR TAB OF THE PDE

PARA Weekly eJournal: April 14, 2021

The link to this Transmittal R10731FM

PARA Weekly eJournal: April 14, 2021

The link to this Transmittal R10727PI

PARA Weekly eJournal: April 14, 2021

The link to this Transmittal R10723PI

PARA Weekly eJournal: April 14, 2021

Creating results through our experience and automated processes.

719.308.0883 Randi Brant ner Vice President of Analytics 719.308.0883 rbrantner@hfri.net